DHR
Danaher Corporation
Hybrid Industrial
★ Quality 23/100Price today
$207.66
This company value is already calculated
We know what it is worth from its audited numbers, and whether it trades above or below that today. Create your free account to see it.
See what it is worthcharlieapp.co
What this business is made of
The business
They bought gold during the COVID fever; now they're paying for the inventory hangover.
Danaher sells instruments and consumables for life sciences and medical diagnostics: lab equipment, reagents, and bioprocessing tools to manufacture drugs. It makes money on the initial device sale and, above all, on the recurring consumables each test requires.
The real moat is the consumables: once a lab validates a piece of equipment and its reagents, switching means recertifying regulated processes, which is expensive and slow. That generates sticky repeat revenue. But competition is fierce and the model doesn't grant it a dominant edge.
Revenue history
From $29.5B to $24.6B in 4 years. Sales are shrinking — the engine is losing steam.
Where each $100 of sales goes
Revenue $24.6B · FY2025
Of every $100 in sales, $85 goes to costs and operations; $15 is left as net profit (15% margin).
Catalysts and risks
End of bioprocessing destocking: when customers burn through the inventory piled up during the pandemic and start ordering again.
Recovery in biopharma research spending and lab funding.
59% gross margin that protects cash flow if volume rebounds.
The market is already paying for a reacceleration that hasn't arrived; if it's slow, the price is too high.
Debt of $18.4 billion against near-zero cash limits maneuvering room.
Flat growth today: revenue stuck around $24 billion since the Veralto spinoff.
Charlie's note
“A decent-quality business bought at an excellent price: the market pays well above 9x cash flow betting on growth that today is 0%. Paying for hope rarely ends well.”
Analysis · June 2026
Want to follow Danaher Corporation?
We do not calculate a value here: Danaher Corporation does not generate cash flows you can project, and putting a number on it would be making it up. What you can do is follow it and tell us the price you care about — we will email you when it gets there.
🔔 Email meFree · no card
Charlie informs, it doesn't advise. No information should be taken as a recommendation to buy or sell.